Literature DB >> 21110179

Synergistic protection of Danhong injection (丹红注射液) and ischemic postconditioning on myocardial reperfusion injury in minipigs.

Xiao-juan Ma1, Shang-jun Yin, Ji-cheng Jin, Cai-feng Wu, Ye Huang, Da-zhuo Shi, Hui-jun Yin.   

Abstract

OBJECTIVE: To explore the synergistic protection of Danhong Injection (丹红注射液, DHI) and ischemic postconditioning on myocardial reperfusion injury in minipigs.
METHODS: Acute myocardial infarction model was made by balloon occlusion in left anterior descending coronary artery (LAD) of minipigs, and then postconditioning was simulated through inflation/deflation of the angioplasty balloon. Minipigs were divided into four groups: the sham operation group (SH group), the ischemia/reperfusion group (I/R group), the ischemic postconditioning group (POC group) and DHI combined with ischemic postconditioning group (PAD group, DHI 20 mL through ear vein), six in each group. After 24-h continuous observation, myocardial infarction size was assessed by triphenyltetrazolium staining (TTC). Morphological changes of ischemic myocardium were observed by light microscopy, and cardiomyocyte ultrastructure was studied with electron microscopy. The superoxide dismutase (SOD) and malondialdehyde (MDA) activity in heart homogenates were measured by a biochemical method.
RESULTS: The myocardial infarction size was smaller in the POC group than in the I/R group (0.26 ± 0.02 vs. 0.37 ± 0.09, P<0.05), and the PAD group (0.14 ± 0.08) displayed a significantly reduced infarction size relative to the I/R group (P<0.01) and POC group (P<0.05). The damage of myocardial tissue was severe in the I/R group shown by light and electron microscopy: myocardial fibers disorder, sarcoplasmic dissolution, myofilament fracture, mitochondria swelling and even vacuolization formation and a large number of inflammatory cell infiltrations. Compared with the I/R group, reduction of reperfusion injury in the PAD group included more orderly arranged myocardial fibers, less infiltration of inflammatory cells and maintenance of mitochondrial integrity. Compared with the I/R group, the damage of myocardial tissue in the POC group was improved, but not as significant as that in the PAD group. SOD levels in the POC group and the PAD group were significantly higher than those in the I/R group (96.96 ± 13.43, 112.25 ± 22.75 vs. 76.32 ± 10.63, P<0.05), and MDA was significantly lower in the POC group and the PAD group compared to the I/R group (1.27 ± 0.19, 1.09 ± 0.21 vs. 1.47 ± 0.16, P<0.05).
CONCLUSION: DHI and ischemic postconditioning show a synergistic cardioprotection on myocardial reperfusion injury in minipigs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110179     DOI: 10.1007/s11655-010-0567-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  13 in total

1.  The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo.

Authors:  Ya Wen Chen; Chun Fa Huang; Keh Sung Tsai; Rong Sen Yang; Cheng Chieh Yen; Ching Yao Yang; Shoei Yn Lin-Shiau; Shing Hwa Liu
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

2.  Postconditioning inhibits mitochondrial permeability transition.

Authors:  Laurent Argaud; Odile Gateau-Roesch; Olivier Raisky; Joseph Loufouat; Dominique Robert; Michel Ovize
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

3.  Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway.

Authors:  Andrew Tsang; Derek J Hausenloy; Mihaela M Mocanu; Derek M Yellon
Journal:  Circ Res       Date:  2004-07-08       Impact factor: 17.367

4.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

Authors:  Zhi-Qing Zhao; Joel S Corvera; Michael E Halkos; Faraz Kerendi; Ning-Ping Wang; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

5.  Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm.

Authors:  Michael Galagudza; Dmitry Kurapeev; Sarkis Minasian; Guro Valen; Jarle Vaage
Journal:  Eur J Cardiothorac Surg       Date:  2004-06       Impact factor: 4.191

Review 6.  Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations.

Authors:  Jean Pierre Monassier
Journal:  Arch Cardiovasc Dis       Date:  2008-09-20       Impact factor: 2.340

Review 7.  Why do we still not have cardioprotective drugs?

Authors:  James M Downey; Michael V Cohen
Journal:  Circ J       Date:  2009-06-09       Impact factor: 2.993

8.  Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.

Authors:  Derek Hausenloy; Abigail Wynne; Michael Duchen; Derek Yellon
Journal:  Circulation       Date:  2004-04-05       Impact factor: 29.690

Review 9.  Ischemic postconditioning: experimental models and protocol algorithms.

Authors:  Andreas Skyschally; Patrick van Caster; Efstathios K Iliodromitis; Rainer Schulz; Dimitrios T Kremastinos; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2009-06-19       Impact factor: 17.165

10.  Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.

Authors:  Lazaros A Nikolaidis; Sunil Mankad; George G Sokos; Glen Miske; Ankur Shah; Dariush Elahi; Richard P Shannon
Journal:  Circulation       Date:  2004-02-23       Impact factor: 29.690

View more
  13 in total

1.  Effect of Dan Hong injection on PON1, SOD activity and MDA levels in elderly patients with coronary heart disease.

Authors:  Xianming Su; Yajun He; Wei Yang; Ying Wang; Wei Zhang; Ying Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  DanHong injection dose-dependently varies amino acid metabolites and metabolic pathways in the treatment of rats with cerebral ischemia.

Authors:  Zhi-li Guo; Yan Zhu; Xiao-tao Su; Jun Liu; Qian-xu Yang; Jing-yi Nan; Bu-chang Zhao; Ying-ying Zhang; Ya-nan Yu; Bing Li; Hong-bin Xiao; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

3.  Danhong injection attenuates ischemia/reperfusion-induced brain damage which is associating with Nrf2 levels in vivo and in vitro.

Authors:  Hong Guo; Mei-jiao Li; Qing-qing Liu; Li-li Guo; Meng-meng Ma; Shao-xia Wang; Bin Yu; Li-Min Hu
Journal:  Neurochem Res       Date:  2014-07-29       Impact factor: 3.996

4.  Effects of Danhong Injection (丹红注射液) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells.

Authors:  Yu-yan Zhang; Hui-fen Zhou; Jie-hong Yang; Yu He; Xiao-qiang Chen; Katsuyoshi Nishinari; Hao-fang Wan; Hai-tong Wan
Journal:  Chin J Integr Med       Date:  2016-04-09       Impact factor: 1.978

5.  Effect of Danhong Injection Combined with Naoxintong Tablets on Prognosis and Inflammatory Factor Expression in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Yun Lv; Yaping Pan; Yan Gao; Jingqian Lu; Yi Li; Jie Bai; Jing Zhai
Journal:  Acta Cardiol Sin       Date:  2015-07       Impact factor: 2.672

6.  Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury.

Authors:  Shaoxia Wang; Hong Guo; Xumei Wang; Lijuan Chai; Limin Hu; Tao Zhao; Buchang Zhao; Xiaoxu Tan; Feifei Jia
Journal:  Neural Regen Res       Date:  2014-08-01       Impact factor: 5.135

7.  Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection.

Authors:  Ming Lyu; Chun-Lin Yan; Hai-Xin Liu; Tai-Yi Wang; Xin-Hui Shi; Jin-Ping Liu; John Orgah; Guan-Wei Fan; Ji-Hong Han; Xiao-Ying Wang; Yan Zhu
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

Review 8.  Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.

Authors:  Pengda Liao; Lei Wang; Liheng Guo; Ruixiang Zeng; Juming Huang; Minzhou Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-14       Impact factor: 2.629

Review 9.  Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury.

Authors:  Qing Liu; Jiqiang Li; Jing Wang; Jianping Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-31       Impact factor: 2.629

10.  PET Demonstrates Functional Recovery after Treatment by Danhong Injection in a Rat Model of Cerebral Ischemic-Reperfusion Injury.

Authors:  Zefeng Wang; Fahuan Song; Jinhui Li; Yuyan Zhang; Yu He; Jiehong Yang; Huifen Zhou; Tao Zhao; Wei Fu; Panke Xing; Haitong Wan; Mei Tian; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.